CLINICAL_TRIALS
trial_result
· 2011-06-08
Clinical Trial Update: Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl [NA]
Summary
The ULURU Inc. burn-treatment trial evaluating Altrazeal versus a typical carboxymethyl product was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ULURU Inc. | Conditions: Burn | NA | Status: TERMINATED